CrossRef Text and Data Mining

Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.

High-Dose Chemotherapy with Vandervilt Regimen and CSF Support for High-Risk Aggressive Non-Hodgkin's Lymphoma

Bong Seog Kim, Jeong Hoon Yang, Kyung Tae Kim, Baek Yeol Ryoo, Tae You Kim, Young Hyuck Im, Jhin Oh Lee, Tae Woong Kang, Yoon Koo Kang

Cancer Research and Treatment. 1998;30(1):137-149.

Paclitaxel plus high-dose cyclosphosphamide with G-CSF support in patients with relapsed and refactory aggressive non-Hodgkin's lymphoma

British Journal of Haematology. 1998;102(1):678-683

Link1 Link2

Initial high dose chemotherapy plus autologous stem cell support improves survival outcomes compared with a standard CHOP regimen in people with higher intermediate risk aggressive lymphoma☆, ☆☆, ☆☆☆Abstracted from: Milpied N, Deconinck E, Gaillard F, et al. Initial treatment of aggressive lymphoma with high-dose chemotherapy and autologous stem-cell support. N Engl J Med 2004;350:1287–95.

A GLASMACHER

Cancer Treatment Reviews. 2004;30(6):577-582

Link1 Link2

Initial high dose chemotherapy plus autologous stem cell support improves survival outcomes compared with a standard CHOP regimen in people with higher intermediate risk aggressive lymphoma

Axel Glasmacher

Cancer Treatment Reviews. 2004;30(6):577-582

Link1 Link2

CHOP Versus CHOP Plus ESHAP and High-Dose Therapy with Autologous Peripheral Blood Progenitor Cell Transplantation for High-Intermediate–Risk and High-Risk Aggressive Non-Hodgkin's Lymphoma

Tanin Intragumtornchai, Wichai Prayoonwiwat, Tontanai Numbenjapon, Noppadol Assawametha, Rutchanee O'Charoen, Daratana Swasdikul

Clinical Lymphoma. 2000;1(3):219-225

Link1 Link2

Combining Yttrium 90–Labeled Ibritumomab Tiuxetan with High-Dose Chemotherapy and Stem Cell Support in Patients with Relapsed Non-Hodgkin's Lymphoma

Jane N. Winter

Clinical Lymphoma. 2004;5:S22-S26

Link1 Link2

MODELING COST-EFFECTIVENESS OF HIGH DOSE CHEMOTHERAPY AS TREATMENT FOR RELAPSED AGGRESSIVE NON-HODGKIN'S LYMPHOMA IN AN AUSTRALIAN SETTING

Johanes Prajogo, Amanda Neil, Janine Duke, Hong Zhang, Barrie Stokes, Philip Rowlings

Internal Medicine Journal. 2009;

Link1

CyclOBEAP (cyclophosphamide, vincristine, bleomycin, etoposide, doxorubicin, prednisolone) regimen with granulocyte colony-stimulating factor (G-CSF) for patients with aggressive non-Hodgkin's lymphoma: a pilot study

Nozomi Niitsu, Masataka Okamoto, Yasuaki Kuraishi, Shinobu Nakamura, Fumio Kodama, Masami Hirano

European Journal of Haematology. 2000;65(3):188-194

Link1 Link2 Link3

1110 POSTER Early change of F-18 FDG uptake after chemotherapy in aggressive hodgkin's lymphoma and non-Hodgkin's lymphoma: the different pattern of F-18 FDG uptake between aggressive Hodgkin's lymphoma and non-Hodgkin's lymphoma

European Journal of Cancer Supplements. 2005;3(2):320

Link1 Link2

Paclitaxel plus high-dose cyclosphosphamide with G-CSF support in patients with relapsed and refractory aggressive non-Hodgkin's lymphoma

Anas Younes, Jorge Romaguera, Ofelia Mesina, Frederick Hagemeister, Andreas H. Sarris, Maria A. Rodriguez, Peter Mclaughlin, Hector A. Preti, Carlos Bachier, Fernando Cabanillas

British Journal of Haematology. 1998;103(3):678-683

Link1 Link2 Link3

Commentary on “CHOP Chemotherapy with Preemptive Granulocyte Colony-Stimulating Factor in Elderly Patients with Aggressive Non-Hodgkin's Lymphoma: A Dose-Intensity Analysis”

Thomas M. Habermann

Clinical Lymphoma. 2000;1(3):218

Link1 Link2

This metadata service is kindly provided by CrossRef from May 29, 2014. Cancer Res Treat has participated in CrossRef Text and Data Mining service since October 29, 2014.